Intervention

fluoxetine

ClinicalTrials.gov intervention label

Clinical trials11
Recruiting0
Common conditions10
Lead sponsors shown8

Clinical trials

11 shown
Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaNCT02593734 · 2013-07-01
COMPLETED
Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionNCT01824433 · 2013-03-07
COMPLETED
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDNCT01372150 · 2011-11-17
COMPLETED
A Study in the Treatment of Children and Adolescents With Major Depressive DisorderNCT00849901 · 2009-03-01
COMPLETED
A Study in the Treatment of Children and Adolescents With Major Depressive DisorderNCT00849693 · 2009-03-01
COMPLETED
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe DepressionNCT00666757 · 2008-05-01
COMPLETED
Early Prediction of Fluoxetine ResponseNCT01075529 · 2007-03-01
COMPLETED
Fluoxetine and Bupropion to Treat Patients With Depression and AlcoholismNCT00449007 · 2006-02-01
TERMINATED
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerNCT00005850 · 2001-08-01
COMPLETED
Prozac Treatment of Major Depression: Discontinuation StudyNCT00427128 · 1995-11-01
COMPLETED
Neurophysiologic Monitoring of Antidepressant TreatmentNCT01360190 · 1994-08-01
COMPLETED

Trial status mix

COMPLETED10
TERMINATED1

Phase mix

PHASE47
PHASE33
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.